AEterna Zentaris Inc. (USA) In a research issued yesterday, Maxim analyst Jason McCarthy reiterated a Buy rating on shares of AEterna Zentaris Inc.
Keryx Biopharmaceuticals (NASDAQ:KERX), a biopharmaceutical company focused on bringing innovative medicines to people with renal disease, today announced its financial results for the first …
Thursday is a big day for biotech as Gilead Sciences, Inc. (NASDAQ:GILD), Celgene Corporation (NASDAQ:CELG), and Keryx Biopharmaceuticals (NASDAQ:KERX) will all be posting …
Keryx Biopharmaceuticals (NASDAQ:KERX), a biopharmaceutical company focused on bringing innovative medicines to market for people with renal disease, announced appointment of two industry leaders …
Healthcare analysts are weighing in on molecular diagnostics firm TrovaGene Inc (NASDAQ:TROV), pharmaceutical company Keryx Biopharmaceuticals (NASDAQ:KERX), and mological drug maker OHR Pharmaceutical Inc (NASDAQ:OHRP), as the …
Seadrill Ltd (NYSE:SDRL) is down over 7% due to falling oil prices resulting from a series of upcoming events. First, U.
Keryx Biopharmaceuticals (NASDAQ:KERX), a biopharmaceutical company focused on bringing innovative medicines to market for people with renal disease, today announced positive top-line results for …
Biotech stocks are notoriously volatile as a pipeline update or FDA announcement can instantly send share prices through the roof. Below, analysts weigh …
In a research report issued Thursday, Brean Capital analyst Jonathan Aschoff reiterated a Buy rating on shares of Keryx Biopharmaceuticals (NASDAQ:KERX), while slashing the price …
While the biotech tape remains a challenging one, Maxim analysts remain positive on drug maker Keryx Biopharmaceuticals (NASDAQ:KERX) and gene-therapy-product maker bluebird bio Inc (NASDAQ:BLUE). Below …
